Clinical Trial Update: Whey Protein on Posprandial Glucose, Insulin GLP-1, GIP and DPP4 in Type 2 Diabetes [NA]

View source ↗

Summary

Completed clinical trial evaluating whey protein's effects on postprandial glucose, insulin GLP-1, GIP, and DPP-4 in Type 2 Diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Whey Protein

Snippet

Sponsor: Tel Aviv University | Conditions: Type 2 Diabetes Mellitus | NA | Status: COMPLETED